These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 33961518)
1. Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis. Dzobo K; Sinkala M OMICS; 2021 May; 25(5):313-332. PubMed ID: 33961518 [TBL] [Abstract][Full Text] [Related]
2. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma. Geng S; Guo Y; Wang Q; Li L; Wang J Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085 [TBL] [Abstract][Full Text] [Related]
3. Distinct biological characterization of the CD44 and CD90 phenotypes of cancer stem cells in gastric cancer cell lines. Shu X; Liu H; Pan Y; Sun L; Yu L; Sun L; Yang Z; Ran Y Mol Cell Biochem; 2019 Sep; 459(1-2):35-47. PubMed ID: 31073886 [TBL] [Abstract][Full Text] [Related]
4. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer. Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890 [TBL] [Abstract][Full Text] [Related]
5. CD44 Sorted Cells Have an Augmented Potential for Proliferation, Epithelial-Mesenchymal Transition, Stemness, and a Predominantly Inflammatory Cytokine and Angiogenic Secretome. Patil S Curr Issues Mol Biol; 2021 Jun; 43(1):423-433. PubMed ID: 34205649 [TBL] [Abstract][Full Text] [Related]
6. siRNA-induced CD44 knockdown suppresses the proliferation and invasion of colorectal cancer stem cells through inhibiting epithelial-mesenchymal transition. Zou W; Zhang Y; Bai G; Zhuang J; Wei L; Wang Z; Sun M; Wang J J Cell Mol Med; 2022 Apr; 26(7):1969-1978. PubMed ID: 35229451 [TBL] [Abstract][Full Text] [Related]
7. Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX. Palagani V; El Khatib M; Kossatz U; Bozko P; Müller MR; Manns MP; Krech T; Malek NP; Plentz RR PLoS One; 2012; 7(10):e46514. PubMed ID: 23094026 [TBL] [Abstract][Full Text] [Related]
8. Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers. Kim TM; Ko YH; Ha SJ; Lee HH BMC Cancer; 2019 Feb; 19(1):119. PubMed ID: 30717708 [TBL] [Abstract][Full Text] [Related]
9. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer. Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895 [TBL] [Abstract][Full Text] [Related]
10. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma. Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202 [TBL] [Abstract][Full Text] [Related]
11. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer. Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827 [TBL] [Abstract][Full Text] [Related]
12. Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling. Wu CT; Lin WY; Chen WC; Chen MF Ann Surg Oncol; 2018 Nov; 25(12):3518-3526. PubMed ID: 30128900 [TBL] [Abstract][Full Text] [Related]
13. miR‑196a‑5p modulates gastric cancer stem cell characteristics by targeting Smad4. Pan Y; Shu X; Sun L; Yu L; Sun L; Yang Z; Ran Y Int J Oncol; 2017 Jun; 50(6):1965-1976. PubMed ID: 28440445 [TBL] [Abstract][Full Text] [Related]
14. Enrichment of cancer stem-like cells by the induction of epithelial-mesenchymal transition using lentiviral vector carrying E-cadherin shRNA in HT29 cell line. Saltanatpour Z; Johari B; Alizadeh A; Lotfinia M; Majidzadeh-A K; Nikbin B; Kadivar M J Cell Physiol; 2019 Dec; 234(12):22935-22946. PubMed ID: 31111504 [TBL] [Abstract][Full Text] [Related]
15. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance. Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737 [TBL] [Abstract][Full Text] [Related]
16. CD44: A Multifunctional Mediator of Cancer Progression. Hassn Mesrati M; Syafruddin SE; Mohtar MA; Syahir A Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944493 [TBL] [Abstract][Full Text] [Related]
17. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells. Alberti L; Losi L; Leyvraz S; Benhattar J PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996 [TBL] [Abstract][Full Text] [Related]
18. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis. Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses. Xia P; Xu XY Oncotarget; 2016 Jul; 7(29):45538-45546. PubMed ID: 27323782 [TBL] [Abstract][Full Text] [Related]
20. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells. Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]